Drug Shortage Report for AURO-EZETIMIBE
Report ID | 135358 |
Drug Identification Number | 02469286 |
Brand name | AURO-EZETIMIBE |
Common or Proper name | Ezetimibe |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | EZETIMIBE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100's and 30's |
ATC code | C10AX |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-12-09 |
Estimated end date | 2024-05-01 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2024-04-16 | French | Compare |
v12 | 2024-04-16 | English | Compare |
v11 | 2024-04-05 | French | Compare |
v10 | 2024-04-05 | English | Compare |
v9 | 2024-03-13 | French | Compare |
v8 | 2024-03-13 | English | Compare |
v7 | 2024-02-27 | French | Compare |
v6 | 2024-02-27 | English | Compare |
v5 | 2024-02-12 | French | Compare |
v4 | 2024-02-12 | English | Compare |
v3 | 2021-03-10 | English | Compare |
v2 | 2021-03-09 | French | Compare |
v1 | 2021-03-09 | English | Compare |
Showing 1 to 13 of 13